REPORT ID 3866

Asia-Pacific Circulating Tumor Cells Market Report 2017

Publish Date
14-Dec-17
Pages
117
Format
Electronic (PDF)

In this report, the Asia-Pacific Circulating Tumor Cells market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Circulating Tumor Cells for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Circulating Tumor Cells market competition by top manufacturers/players, with Circulating Tumor Cells sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Janssen
    Qiagen?Adnagen?
    Acousys Biodevices
    ApoCell
    Advanced Cell Diagnostics
    Fluxion Biosciences
    Biocept
    Fluidigm
    Epic Sciences
    Clearbridge Biomedics
    Cynvenio
    CytoTrack
    ScreenCell
    Creatv Microtech
    Aviva Biosciences
    Greiner Bio-one
    Sysmex
    Ikonisys

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    CTC Enrichment
    CTC Detection
    CTC Analysis

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Prostate Cancer
    Breast Cancer
    Colorectal Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Circulating Tumor Cells Market Report 2017
1 Circulating Tumor Cells Overview
    1.1 Product Overview and Scope of Circulating Tumor Cells
    1.2 Classification of Circulating Tumor Cells by Product Category
        1.2.1 Asia-Pacific Circulating Tumor Cells Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Circulating Tumor Cells Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 CTC Enrichment
        1.2.4 CTC Detection
        1.2.5 CTC Analysis
    1.3 Asia-Pacific Circulating Tumor Cells Market by Application/End Users
        1.3.1 Asia-Pacific Circulating Tumor Cells Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Prostate Cancer
        1.3.3 Breast Cancer
        1.3.4 Colorectal Cancer
        1.3.5 Others
    1.4 Asia-Pacific Circulating Tumor Cells Market by Region
        1.4.1 Asia-Pacific Circulating Tumor Cells Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Circulating Tumor Cells (2012-2022)
        1.5.1 Asia-Pacific Circulating Tumor Cells Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Circulating Tumor Cells Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Circulating Tumor Cells Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Circulating Tumor Cells Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Circulating Tumor Cells Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Circulating Tumor Cells Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Circulating Tumor Cells (Volume and Value) by Type
        2.2.1 Asia-Pacific Circulating Tumor Cells Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Circulating Tumor Cells Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Circulating Tumor Cells (Volume) by Application
    2.4 Asia-Pacific Circulating Tumor Cells (Volume and Value) by Region
        2.4.1 Asia-Pacific Circulating Tumor Cells Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Circulating Tumor Cells Revenue and Market Share by Region (2012-2017)

3 China Circulating Tumor Cells (Volume, Value and Sales Price)
    3.1 China Circulating Tumor Cells Sales and Value (2012-2017)
        3.1.1 China Circulating Tumor Cells Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Circulating Tumor Cells Revenue and Growth Rate (2012-2017)
        3.1.3 China Circulating Tumor Cells Sales Price Trend (2012-2017)
    3.2 China Circulating Tumor Cells Sales Volume and Market Share by Type
    3.3 China Circulating Tumor Cells Sales Volume and Market Share by Application

4 Japan Circulating Tumor Cells (Volume, Value and Sales Price)
    4.1 Japan Circulating Tumor Cells Sales and Value (2012-2017)
        4.1.1 Japan Circulating Tumor Cells Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Circulating Tumor Cells Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Circulating Tumor Cells Sales Price Trend (2012-2017)
    4.2 Japan Circulating Tumor Cells Sales Volume and Market Share by Type
    4.3 Japan Circulating Tumor Cells Sales Volume and Market Share by Application

5 South Korea Circulating Tumor Cells (Volume, Value and Sales Price)
    5.1 South Korea Circulating Tumor Cells Sales and Value (2012-2017)
        5.1.1 South Korea Circulating Tumor Cells Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Circulating Tumor Cells Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Circulating Tumor Cells Sales Price Trend (2012-2017)
    5.2 South Korea Circulating Tumor Cells Sales Volume and Market Share by Type
    5.3 South Korea Circulating Tumor Cells Sales Volume and Market Share by Application

6 Taiwan Circulating Tumor Cells (Volume, Value and Sales Price)
    6.1 Taiwan Circulating Tumor Cells Sales and Value (2012-2017)
        6.1.1 Taiwan Circulating Tumor Cells Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Circulating Tumor Cells Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Circulating Tumor Cells Sales Price Trend (2012-2017)
    6.2 Taiwan Circulating Tumor Cells Sales Volume and Market Share by Type
    6.3 Taiwan Circulating Tumor Cells Sales Volume and Market Share by Application

7 India Circulating Tumor Cells (Volume, Value and Sales Price)
    7.1 India Circulating Tumor Cells Sales and Value (2012-2017)
        7.1.1 India Circulating Tumor Cells Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Circulating Tumor Cells Revenue and Growth Rate (2012-2017)
        7.1.3 India Circulating Tumor Cells Sales Price Trend (2012-2017)
    7.2 India Circulating Tumor Cells Sales Volume and Market Share by Type
    7.3 India Circulating Tumor Cells Sales Volume and Market Share by Application

8 Southeast Asia Circulating Tumor Cells (Volume, Value and Sales Price)
    8.1 Southeast Asia Circulating Tumor Cells Sales and Value (2012-2017)
        8.1.1 Southeast Asia Circulating Tumor Cells Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Circulating Tumor Cells Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Circulating Tumor Cells Sales Price Trend (2012-2017)
    8.2 Southeast Asia Circulating Tumor Cells Sales Volume and Market Share by Type
    8.3 Southeast Asia Circulating Tumor Cells Sales Volume and Market Share by Application

9 Australia Circulating Tumor Cells (Volume, Value and Sales Price)
    9.1 Australia Circulating Tumor Cells Sales and Value (2012-2017)
        9.1.1 Australia Circulating Tumor Cells Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Circulating Tumor Cells Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Circulating Tumor Cells Sales Price Trend (2012-2017)
    9.2 Australia Circulating Tumor Cells Sales Volume and Market Share by Type
    9.3 Australia Circulating Tumor Cells Sales Volume and Market Share by Application

10 Asia-Pacific Circulating Tumor Cells Players/Suppliers Profiles and Sales Data
    10.1 Janssen
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Circulating Tumor Cells Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Janssen Circulating Tumor Cells Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Qiagen?Adnagen?
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Circulating Tumor Cells Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Qiagen?Adnagen? Circulating Tumor Cells Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Acousys Biodevices
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Circulating Tumor Cells Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Acousys Biodevices Circulating Tumor Cells Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 ApoCell
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Circulating Tumor Cells Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 ApoCell Circulating Tumor Cells Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Advanced Cell Diagnostics
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Circulating Tumor Cells Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Advanced Cell Diagnostics Circulating Tumor Cells Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Fluxion Biosciences
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Circulating Tumor Cells Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Fluxion Biosciences Circulating Tumor Cells Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Biocept
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Circulating Tumor Cells Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Biocept Circulating Tumor Cells Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Fluidigm
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Circulating Tumor Cells Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Fluidigm Circulating Tumor Cells Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Epic Sciences
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Circulating Tumor Cells Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Epic Sciences Circulating Tumor Cells Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Clearbridge Biomedics
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Circulating Tumor Cells Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Clearbridge Biomedics Circulating Tumor Cells Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 Cynvenio
    10.12 CytoTrack
    10.13 ScreenCell
    10.14 Creatv Microtech
    10.15 Aviva Biosciences
    10.16 Greiner Bio-one
    10.17 Sysmex
    10.18 Ikonisys

11 Circulating Tumor Cells Manufacturing Cost Analysis
    11.1 Circulating Tumor Cells Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Circulating Tumor Cells

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Circulating Tumor Cells Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Circulating Tumor Cells Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Circulating Tumor Cells Market Forecast (2017-2022)
    15.1 Asia-Pacific Circulating Tumor Cells Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Circulating Tumor Cells Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Circulating Tumor Cells Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Circulating Tumor Cells Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Circulating Tumor Cells Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Circulating Tumor Cells Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Circulating Tumor Cells Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Circulating Tumor Cells Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Circulating Tumor Cells Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Circulating Tumor Cells Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Circulating Tumor Cells Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Circulating Tumor Cells Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Circulating Tumor Cells Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Circulating Tumor Cells Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Circulating Tumor Cells Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Circulating Tumor Cells Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Circulating Tumor Cells Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Circulating Tumor Cells Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Circulating Tumor Cells Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer